methylene blue has been researched along with Hypoxia-Ischemia, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Lu, Y; Wen, J; Xu, J; Yang, L; Zhang, G; Zhang, Q | 1 |
| Choudhury, GR; Li, W; Liu, R; Ryou, MG; Winters, A; Yang, SH; Yuan, F | 1 |
2 other study(ies) available for methylene blue and Hypoxia-Ischemia, Brain
| Article | Year |
|---|---|
Methylene blue post-treatment improves hypoxia-ischemic recovery in a neonatal rat model.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Female; Hypoxia-Ischemia, Brain; Male; Methylene Blue; Rats; Rats, Sprague-Dawley; Recovery of Function; Treatment Outcome | 2020 |
Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress.
Topics: Adenosine Triphosphate; Animals; Cell Hypoxia; Cell Line; Glucose; Hippocampus; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Ischemia, Brain; Methylene Blue; Mice, Inbred C57BL; Neuroprotective Agents; Oxygen; Reperfusion Injury; Stress, Physiological | 2015 |